Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis
BackgroundNeuropilin (NRP) is a transmembrane protein, which has been shown to be a pro-angiogenic mediator and implicated as a potential driver of cancer progression. NRP-1 up-regulation in ovarian cancer tissue predicts poor prognosis. However, the clinical relevance of the soluble form of NRP-1 (...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 October 2022
|
| In: |
Frontiers in oncology
Year: 2022, Jahrgang: 12, Pages: 1-10 |
| ISSN: | 2234-943X |
| DOI: | 10.3389/fonc.2022.974885 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fonc.2022.974885 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fonc.2022.974885 
|
| Verfasserangaben: | Daniel Martin Klotz, Jan Dominik Kuhlmann, Theresa Link, Maren Goeckenjan, Lorenz C. Hofbauer, Andy Göbel, Tilman D. Rachner and Pauline Wimberger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1830824430 | ||
| 003 | DE-627 | ||
| 005 | 20230525082655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230111s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fonc.2022.974885 |2 doi | |
| 035 | |a (DE-627)1830824430 | ||
| 035 | |a (DE-599)KXP1830824430 | ||
| 035 | |a (OCoLC)1361669376 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Klotz, Daniel Martin |e VerfasserIn |0 (DE-588)1200031474 |0 (DE-627)1682191524 |4 aut | |
| 245 | 1 | 0 | |a Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis |c Daniel Martin Klotz, Jan Dominik Kuhlmann, Theresa Link, Maren Goeckenjan, Lorenz C. Hofbauer, Andy Göbel, Tilman D. Rachner and Pauline Wimberger |
| 264 | 1 | |c 21 October 2022 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.01.2023 | ||
| 520 | |a BackgroundNeuropilin (NRP) is a transmembrane protein, which has been shown to be a pro-angiogenic mediator and implicated as a potential driver of cancer progression. NRP-1 up-regulation in ovarian cancer tissue predicts poor prognosis. However, the clinical relevance of the soluble form of NRP-1 (sNRP-1) as a circulating biomarker in ovarian cancer patients is unknown.Methods/patients cohortsNRP-1 levels were quantified in a cohort of 88 clinically documented ovarian cancer patients by a commercially available sNRP-1 enzyme-linked immunosorbent assay (ELISA) kit (Biomedica, Vienna, Austria). Patients (81.8% with FIGOIII/IV) received primary cytoreductive surgery with the aim of macroscopic complete resection (achieved in 55.7% of patients) and the recommendation of adjuvant chemotherapy in line with national guidelines.ResultsHigher levels of sNRP-1 reflected more advanced disease (FIGO III/IV) and indicated a trend towards suboptimal surgical outcome, i.e. any residual tumor. sNRP-1 was neither related to the patients’ age nor the BRCA1/2 mutational status. Patients with higher sNRP-1 levels at primary diagnosis had a significantly reduced progression-free survival (PFS) (HR = 0.541, 95%CI: 0.304 - 0.963; p = 0.037) and overall survival (OS) (HR = 0.459, 95%CI: 0.225 - 0.936; p = 0.032). Principal component analysis showed that sNRP-1 levels were unrelated to the circulating hepatocyte growth factor (HGF) and the soluble ectodomain of its receptor the tyrosine kinase mesenchymal-epithelial transition (c-MET), suggesting that there is no proportional serological concentration gradient of soluble components of the NRP-1/HGF/c-MET signaling axis.ConclusionsIn line with the previously shown tissue-based prognostic role, we demonstrated for the first time that sNRP-1 can also act as a readily accessible, prognostic biomarker in the circulation of patients with ovarian cancer at primary diagnosis. Given its known role in angiogenesis and conferring resistance to the poly ADP-ribose polymerase (PARP) inhibitor olaparib in vitro, our results encourage more detailed investigation into sNRP-1 as a potential predictive biomarker for bevacizumab and/or PARP-inhibitor treatment. | ||
| 700 | 1 | |a Kuhlmann, Jan Dominik |d 1983- |e VerfasserIn |0 (DE-588)1034875000 |0 (DE-627)746436874 |0 (DE-576)382489691 |4 aut | |
| 700 | 1 | |a Link, Theresa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goeckenjan, Maren |d 1970- |e VerfasserIn |0 (DE-588)120340534 |0 (DE-627)080614140 |0 (DE-576)29216761X |4 aut | |
| 700 | 1 | |a Hofbauer, Lorenz C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Göbel, Andy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rachner, Tilman D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wimberger, Pauline |d 1971- |e VerfasserIn |0 (DE-588)121614859 |0 (DE-627)705574733 |0 (DE-576)292800061 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in oncology |d Lausanne : Frontiers Media, 2011 |g 12(2022) vom: Okt., Artikel-ID 974885, Seite 1-10 |h Online-Ressource |w (DE-627)684965518 |w (DE-600)2649216-7 |w (DE-576)35841184X |x 2234-943X |7 nnas |a Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g month:10 |g elocationid:974885 |g pages:1-10 |g extent:10 |a Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fonc.2022.974885 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fonc.2022.974885 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230111 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 121614859 |a Wimberger, Pauline |m 121614859:Wimberger, Pauline |p 8 |y j | ||
| 998 | |g 120340534 |a Goeckenjan, Maren |m 120340534:Goeckenjan, Maren |d 50000 |e 50000PG120340534 |k 0/50000/ |p 4 | ||
| 998 | |g 1034875000 |a Kuhlmann, Jan Dominik |m 1034875000:Kuhlmann, Jan Dominik |p 2 | ||
| 998 | |g 1200031474 |a Klotz, Daniel Martin |m 1200031474:Klotz, Daniel Martin |p 1 |x j | ||
| 999 | |a KXP-PPN1830824430 |e 4246177474 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Daniel Martin","display":"Klotz, Daniel Martin","family":"Klotz"},{"given":"Jan Dominik","role":"aut","family":"Kuhlmann","display":"Kuhlmann, Jan Dominik"},{"display":"Link, Theresa","family":"Link","given":"Theresa","role":"aut"},{"display":"Goeckenjan, Maren","family":"Goeckenjan","role":"aut","given":"Maren"},{"given":"Lorenz C.","role":"aut","display":"Hofbauer, Lorenz C.","family":"Hofbauer"},{"role":"aut","given":"Andy","display":"Göbel, Andy","family":"Göbel"},{"display":"Rachner, Tilman D.","family":"Rachner","role":"aut","given":"Tilman D."},{"family":"Wimberger","display":"Wimberger, Pauline","role":"aut","given":"Pauline"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"21 October 2022"}],"note":["Gesehen am 11.01.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis","title_sort":"Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis"}],"language":["eng"],"name":{"displayForm":["Daniel Martin Klotz, Jan Dominik Kuhlmann, Theresa Link, Maren Goeckenjan, Lorenz C. Hofbauer, Andy Göbel, Tilman D. Rachner and Pauline Wimberger"]},"physDesc":[{"extent":"10 S."}],"recId":"1830824430","relHost":[{"language":["eng"],"title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"note":["Gesehen am 07.11.13"],"origin":[{"publisher":"Frontiers Media","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"Lausanne"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"pages":"1-10","text":"12(2022) vom: Okt., Artikel-ID 974885, Seite 1-10","year":"2022","volume":"12","extent":"10"},"disp":"Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axisFrontiers in oncology","id":{"eki":["684965518"],"issn":["2234-943X"],"zdb":["2649216-7"]},"pubHistory":["2011 -"],"recId":"684965518","physDesc":[{"extent":"Online-Ressource"}]}],"id":{"doi":["10.3389/fonc.2022.974885"],"eki":["1830824430"]}} | ||
| SRT | |a KLOTZDANIECLINICALIM2120 | ||